Neurocrine bags FDA approval for new ‘sprinkle’ Ingrezza formulation
The sprinkle formulation of Ingrezza is approved as an alternative for Huntington’s patients who have difficulty swallowing.
The sprinkle formulation of Ingrezza is approved as an alternative for Huntington’s patients who have difficulty swallowing.
GSK, Lundbeck, and ROVI share how their events strategies contribute to higher-value engagement with healthcare professionals (HCPs). By Jenna Sherlock-Goudet, Veeva's Director of Commercial Strategy, Europe.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
NIH team develops AI tool to predict cancer drug response
TetraScience and Google Cloud link for AI-driven drug developments
Bayer and Google Cloud to develop AI solutions for radiologists
Q&A: BARDA wants to back tech that can combat multiple infections, says director